nodes	percent_of_prediction	percent_of_DWPC	metapath
Papaverine—Vertigo—Mechlorethamine—lymphatic system cancer	0.032	0.032	CcSEcCtD
Papaverine—Flushing—Teniposide—lymphatic system cancer	0.028	0.028	CcSEcCtD
Papaverine—Anorexia—Mechlorethamine—lymphatic system cancer	0.0277	0.0277	CcSEcCtD
Papaverine—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.0252	0.0252	CcSEcCtD
Papaverine—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.0214	0.0214	CcSEcCtD
Papaverine—Malaise—Fludarabine—lymphatic system cancer	0.0208	0.0208	CcSEcCtD
Papaverine—Anorexia—Teniposide—lymphatic system cancer	0.0204	0.0204	CcSEcCtD
Papaverine—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.0199	0.0199	CcSEcCtD
Papaverine—Discomfort—Fludarabine—lymphatic system cancer	0.0194	0.0194	CcSEcCtD
Papaverine—Decreased appetite—Teniposide—lymphatic system cancer	0.0186	0.0186	CcSEcCtD
Papaverine—Rash—Mechlorethamine—lymphatic system cancer	0.0183	0.0183	CcSEcCtD
Papaverine—Dermatitis—Mechlorethamine—lymphatic system cancer	0.0183	0.0183	CcSEcCtD
Papaverine—Flushing—Bleomycin—lymphatic system cancer	0.018	0.018	CcSEcCtD
Papaverine—Anorexia—Fludarabine—lymphatic system cancer	0.0179	0.0179	CcSEcCtD
Papaverine—Feeling abnormal—Teniposide—lymphatic system cancer	0.0176	0.0176	CcSEcCtD
Papaverine—Nausea—Mechlorethamine—lymphatic system cancer	0.0172	0.0172	CcSEcCtD
Papaverine—Decreased appetite—Fludarabine—lymphatic system cancer	0.0164	0.0164	CcSEcCtD
Papaverine—Constipation—Fludarabine—lymphatic system cancer	0.0161	0.0161	CcSEcCtD
Papaverine—Hepatitis—Mitoxantrone—lymphatic system cancer	0.0158	0.0158	CcSEcCtD
Papaverine—Flushing—Carmustine—lymphatic system cancer	0.0157	0.0157	CcSEcCtD
Papaverine—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.0157	0.0157	CcSEcCtD
Papaverine—Feeling abnormal—Fludarabine—lymphatic system cancer	0.0155	0.0155	CcSEcCtD
Papaverine—Malaise—Bleomycin—lymphatic system cancer	0.0152	0.0152	CcSEcCtD
Papaverine—Diarrhoea—Teniposide—lymphatic system cancer	0.0146	0.0146	CcSEcCtD
Papaverine—Discomfort—Bleomycin—lymphatic system cancer	0.0142	0.0142	CcSEcCtD
Papaverine—Rash—Teniposide—lymphatic system cancer	0.0135	0.0135	CcSEcCtD
Papaverine—Dermatitis—Teniposide—lymphatic system cancer	0.0135	0.0135	CcSEcCtD
Papaverine—Headache—Teniposide—lymphatic system cancer	0.0134	0.0134	CcSEcCtD
Papaverine—Anorexia—Bleomycin—lymphatic system cancer	0.0131	0.0131	CcSEcCtD
Papaverine—Diarrhoea—Fludarabine—lymphatic system cancer	0.0129	0.0129	CcSEcCtD
Papaverine—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.0127	0.0127	CcSEcCtD
Papaverine—Nausea—Teniposide—lymphatic system cancer	0.0127	0.0127	CcSEcCtD
Papaverine—Vertigo—Vincristine—lymphatic system cancer	0.0127	0.0127	CcSEcCtD
Papaverine—Malaise—Mitoxantrone—lymphatic system cancer	0.0124	0.0124	CcSEcCtD
Papaverine—Decreased appetite—Bleomycin—lymphatic system cancer	0.012	0.012	CcSEcCtD
Papaverine—Rash—Fludarabine—lymphatic system cancer	0.0119	0.0119	CcSEcCtD
Papaverine—Dermatitis—Fludarabine—lymphatic system cancer	0.0118	0.0118	CcSEcCtD
Papaverine—Headache—Fludarabine—lymphatic system cancer	0.0118	0.0118	CcSEcCtD
Papaverine—Discomfort—Mitoxantrone—lymphatic system cancer	0.0115	0.0115	CcSEcCtD
Papaverine—Anorexia—Carmustine—lymphatic system cancer	0.0115	0.0115	CcSEcCtD
Papaverine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.0114	0.0114	CcSEcCtD
Papaverine—Nausea—Fludarabine—lymphatic system cancer	0.0112	0.0112	CcSEcCtD
Papaverine—Anorexia—Vincristine—lymphatic system cancer	0.011	0.011	CcSEcCtD
Papaverine—Anorexia—Mitoxantrone—lymphatic system cancer	0.0107	0.0107	CcSEcCtD
Papaverine—Decreased appetite—Carmustine—lymphatic system cancer	0.0105	0.0105	CcSEcCtD
Papaverine—Constipation—Carmustine—lymphatic system cancer	0.0103	0.0103	CcSEcCtD
Papaverine—Decreased appetite—Vincristine—lymphatic system cancer	0.00999	0.00999	CcSEcCtD
Papaverine—Feeling abnormal—Carmustine—lymphatic system cancer	0.00992	0.00992	CcSEcCtD
Papaverine—Constipation—Vincristine—lymphatic system cancer	0.00983	0.00983	CcSEcCtD
Papaverine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00973	0.00973	CcSEcCtD
Papaverine—Constipation—Mitoxantrone—lymphatic system cancer	0.00957	0.00957	CcSEcCtD
Papaverine—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.0094	0.0094	CcSEcCtD
Papaverine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00922	0.00922	CcSEcCtD
Papaverine—Rash—Bleomycin—lymphatic system cancer	0.0087	0.0087	CcSEcCtD
Papaverine—Dermatitis—Bleomycin—lymphatic system cancer	0.00869	0.00869	CcSEcCtD
Papaverine—Diarrhoea—Carmustine—lymphatic system cancer	0.00824	0.00824	CcSEcCtD
Papaverine—Nausea—Bleomycin—lymphatic system cancer	0.00819	0.00819	CcSEcCtD
Papaverine—Diarrhoea—Vincristine—lymphatic system cancer	0.00786	0.00786	CcSEcCtD
Papaverine—Hepatitis—Methotrexate—lymphatic system cancer	0.00785	0.00785	CcSEcCtD
Papaverine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00766	0.00766	CcSEcCtD
Papaverine—Rash—Carmustine—lymphatic system cancer	0.00759	0.00759	CcSEcCtD
Papaverine—Dermatitis—Carmustine—lymphatic system cancer	0.00758	0.00758	CcSEcCtD
Papaverine—Headache—Carmustine—lymphatic system cancer	0.00754	0.00754	CcSEcCtD
Papaverine—Rash—Vincristine—lymphatic system cancer	0.00725	0.00725	CcSEcCtD
Papaverine—Dermatitis—Vincristine—lymphatic system cancer	0.00724	0.00724	CcSEcCtD
Papaverine—Headache—Vincristine—lymphatic system cancer	0.0072	0.0072	CcSEcCtD
Papaverine—Nausea—Carmustine—lymphatic system cancer	0.00715	0.00715	CcSEcCtD
Papaverine—Rash—Mitoxantrone—lymphatic system cancer	0.00706	0.00706	CcSEcCtD
Papaverine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00705	0.00705	CcSEcCtD
Papaverine—Headache—Mitoxantrone—lymphatic system cancer	0.00701	0.00701	CcSEcCtD
Papaverine—Nausea—Vincristine—lymphatic system cancer	0.00683	0.00683	CcSEcCtD
Papaverine—Nausea—Mitoxantrone—lymphatic system cancer	0.00665	0.00665	CcSEcCtD
Papaverine—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.00634	0.00634	CcSEcCtD
Papaverine—Malaise—Methotrexate—lymphatic system cancer	0.00616	0.00616	CcSEcCtD
Papaverine—Vertigo—Methotrexate—lymphatic system cancer	0.00614	0.00614	CcSEcCtD
Papaverine—Discomfort—Methotrexate—lymphatic system cancer	0.00575	0.00575	CcSEcCtD
Papaverine—Anorexia—Methotrexate—lymphatic system cancer	0.00532	0.00532	CcSEcCtD
Papaverine—Decreased appetite—Methotrexate—lymphatic system cancer	0.00485	0.00485	CcSEcCtD
Papaverine—Feeling abnormal—Methotrexate—lymphatic system cancer	0.0046	0.0046	CcSEcCtD
Papaverine—Diarrhoea—Methotrexate—lymphatic system cancer	0.00382	0.00382	CcSEcCtD
Papaverine—Rash—Methotrexate—lymphatic system cancer	0.00352	0.00352	CcSEcCtD
Papaverine—Dermatitis—Methotrexate—lymphatic system cancer	0.00351	0.00351	CcSEcCtD
Papaverine—Headache—Methotrexate—lymphatic system cancer	0.00349	0.00349	CcSEcCtD
Papaverine—Nausea—Methotrexate—lymphatic system cancer	0.00331	0.00331	CcSEcCtD
